By CA Surekha S Ahuja
Valuation Defences, Judicial Principles, and Mistakes to Avoid
Section 56(2)(viib) continues to be one of the most heavily litigated provisions for early-stage companies, despite the existence of DPIIT exemptions and multiple CBDT clarifications. Assessments in recent years show a clear pattern: whenever the share premium appears high or documentation is weak, scrutiny teams invoke the provision aggressively.
The most recent case (details withheld for confidentiality) reinforces a long-standing judicial principle: valuation cannot be rejected merely because the startup later underperformed — it can be rejected only when it is unsupported, inconsistent, or lacking contemporaneous evidence.
This article brings together the legal structure, the current litigation trends, the ground-tested defences, and the most common mistakes that lead to additions.
Core Legal Structure of Section 56(2)(viib)
The provision taxes any excess of issue price over the Fair Market Value (FMV) of shares issued by a closely-held company to a resident investor.
Rule 11UA(2) allows two methods:
-
Net Asset Value (NAV) Method, or
-
Discounted Cash Flow (DCF) Method, certified by a Merchant Banker.
The assessee’s method choice is legally protected, unless the AO establishes perversity or lack of evidence.
The litigation begins when documentation behind the valuation is incomplete or internally inconsistent.
Why Notices Have Increased: The 4 Most Common Triggers Seen in Scrutiny
Recent assessments (including the present case) highlight four consistent triggers:
-
High share premium without commercial justification
-
DCF projections not supported with market studies or investor documents
-
Mismatch between merchant banker valuation and board/investor agreements
-
Non-availability of underlying valuation workings
In the present case, the addition survived solely because the assessee failed to produce working papers behind the DCF model.
Judicial Principles: What Courts Consistently Uphold
A synthesis of all major judgments yields three clear principles:
(a) Valuation is a forward-looking estimate
Courts reiterate that future cash flows cannot be tested by hindsight performance.
(b) AO cannot substitute the assessee’s valuation arbitrarily
The AO must show specific errors — not subjective disagreement.
(c) Startups are entitled to premium based on potential
DCF is built on potential, market opportunity, and scalability, not present turnover.
However, every favourable judgment relies on strong documentation.
What the Present Case Shows
The current matter delivers the most valuable takeaway for startups:
A valuation report is NOT a defence unless assumptions and workings are contemporaneously documented and verifiable.
The AO requested:
-
Discount rate derivation
-
Market sizing evidence
-
Comparable company basis
-
Revenue model and pricing justification
Because these were not furnished, the addition was upheld.
The Most Common Mistakes That Lead to Additions
Every failed 56(2)(viib) defence contains one or more of these lapses:
-
Valuation report without detailed workings
-
DCF assumptions based only on founder-made spreadsheets
-
No market research or comparable evidence
-
Inconsistency between investor term sheet and valuation report
-
Share issue at different prices to different parties without justification
-
Valuation prepared after the date of issue (not contemporaneous)
-
Failure to produce emails, presentations, or internal notes supporting projections
These mistakes make the AO’s job easy.
DPIIT Recognition — Helpful But Not Automatic Protection
DPIIT-recognised startups receive relief only when all conditions under GSR 127(E) are satisfied.
Scrutiny teams still examine:
-
Whether share premium matches business plan
-
Whether funds were used for permitted activities
-
Whether recognition was valid at the time of issue
-
Whether 56(2)(viib) exemption conditions continue to be met
Thus, documentation discipline remains essential even for recognised startups.
The Defence Framework: How to Successfully Defend a Premium (A Practical Template)
This is the litigation-tested defence structure that consistently succeeds:
1. Method Validity (NAV/DCF)
Document why that method reflects the company’s stage and economics.
2. Assumption Evidence
Provide:
-
Market sizing reports
-
Competitor benchmarks
-
Customer pipeline and pricing data
-
CAC, LTV, conversion logic
-
Growth assumptions tied to industry behaviour
3. Merchant Banker Report + Working Files
Include:
-
Discounting logic
-
Terminal value basis
-
Comparable company selection
-
Sensitivity analysis
4. Board & Investor Documentation
Maintain:
-
Board minutes recording valuation rationale
-
Term sheet
-
SHA clauses referencing valuation
-
Emails reflecting investor due diligence
5. Uniform Commercial Conduct
Avoid:
-
Differing share prices in close intervals
-
Back-dated valuations
-
Sudden changes between projections unless explained
This holistic approach makes the defence credible and litigation-proof.
Mistakes to Avoid (High-Risk Red Flags Identified in Assessments)
-
Preparing valuation post-facto
-
Not preserving merchant banker working papers
-
Using generic templates without industry benchmarks
-
Ignoring inconsistencies between projections and actual conduct
-
Treating DPIIT status as a blanket shield
-
Issuing shares to related parties at lower prices
-
Not furnishing calculation logic when AO queries arise
Avoiding these avoids 80% of additions.
Conclusion
Section 56(2)(viib) is not a threat if documentation is credible, contemporaneous, and commercially reasoned.
Valuation should be treated not as an Excel exercise, but as part of a complete valuation ecosystem — one that a company should build before issuing shares, not afterwards.
A method-based, evidence-backed valuation withstands scrutiny.
A report without working papers does not.
